Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-57.8
% (consolidated operating profit)Wording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
2025年４月期 · Full yearPrevious forecast published 2024年６月13日Net Sales9,029→8,027millions
-11.1%
Operating profit454→191millions
-57.8%
Ordinary income461→217millions
-52.9%
Profit attributable to owners of the parent310→199millions
-35.8%
Net income per share54.41→34.97yen
-35.7%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
化学防護服等の受注が当初予想に届かなかったこと、ヘルスケア製品事業が黒字化に至らない見込みであること、猛暑やメーカー在庫調整によりユニフォーム分野の受注が伸びなかったこと。
Previous-period results売上高8,242百万円、営業利益291百万円、経常利益308百万円、親会社株主に帰属する当期純利益187百万円、1株当たり当期純利益33.04円（2024年4月期）
Dividend forecast revision修正なし（期末配当予想1株当たり23.00円）
Consolidated / non-consolidatedConsolidated / non-consolidated (standalone)
| Item | Details |
|---|---|
| Net Sales | ¥9,029 millions → ¥8,027 millions（-11.1%） |
| Operating profit | ¥454 millions → ¥191 millions（-57.8%） |
| Ordinary income | ¥461 millions → ¥217 millions（-52.9%） |
| Profit attributable to owners of the parent | ¥310 millions → ¥199 millions（-35.8%） |
| Net income per share | ¥54.41 yen → ¥34.97 yen |
| Fiscal Period Covered | 2025年４月期 |
| Period Covered | Full year |
| Publication date of previous forecast | 2024年６月13日 |
| Previous-period results | 売上高8,242百万円、営業利益291百万円、経常利益308百万円、親会社株主に帰属する当期純利益187百万円、1株当たり当期純利益33.04円（2024年4月期） |
| Reason for the revision | 化学防護服等の受注が当初予想に届かなかったこと、ヘルスケア製品事業が黒字化に至らない見込みであること、猛暑やメーカー在庫調整によりユニフォーム分野の受注が伸びなかったこと。 |
| Dividend forecast revision | 修正なし（期末配当予想1株当たり23.00円） |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
Details and amount of extraordinary loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.防護服・環境資機材事業では、化学物質管理体制の強化を受けた化学防護服等の受注が当初予想に届かなかった。ヘルスケア製品事業では受注回復や新規開拓、生産効率向上により採算は改善傾向にあるものの、新たな販路による売上増加が途上で黒字化に至らない見込みとなった。ライフマテリアル事業では、猛暑やメーカー在庫調整の影響でスクール・ワーキング等のユニフォーム分野の受注が伸びなかった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.